In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.

Descripción del Articulo

El cáncer de mama triple negativo carece de marcadores pronósticos y predictivos. Se utiliza un estudio fosfoproteómico de alto rendimiento para construir una taxonomía funcional del cáncer de mama triple negativo. En resumen, el presente estudio elucida fosfocitas y quinasas implicadas en el cáncer...

Descripción completa

Detalles Bibliográficos
Autores: Montoya-Suarez, José Luis, Zagorac, Ivana, Fernandez-Gaitero, Sara, Penning, Renske, Post, Harm, Bueno, Maria J., Mouron, Silvana, Manso, Luis, Morente, Manuel M., Alonso, Soledad, Serra, Violeta, Muñoz, Javier, Gómez-López, Gonzalo, Lopez-Acosta, José Francisco, Jimenez-Renard, Veronica, Gris-Oliver, Albert, Al-Shahrour, Fatima, Piñeiro-Yañez, Elena, Apala, Juan V.
Formato: artículo
Fecha de Publicación:2018
Institución:Seguro Social de Salud
Repositorio:ESSALUD-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.essalud.gob.pe:20.500.12959/114
Enlace del recurso:https://hdl.handle.net/20.500.12959/114
Nivel de acceso:acceso abierto
Materia:Oncología
Neoplasias de la mama triple negativas
https://purl.org/pe-repo/ocde/ford#3.05.00
id ESSA_7aee56b4a06af72b7a0c8eb36afd56c7
oai_identifier_str oai:repositorio.essalud.gob.pe:20.500.12959/114
network_acronym_str ESSA
network_name_str ESSALUD-Institucional
repository_id_str 4277
dc.title.es_PE.fl_str_mv In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
title In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
spellingShingle In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
Montoya-Suarez, José Luis
Oncología
Neoplasias de la mama triple negativas
https://purl.org/pe-repo/ocde/ford#3.05.00
title_short In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
title_full In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
title_fullStr In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
title_full_unstemmed In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
title_sort In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
author Montoya-Suarez, José Luis
author_facet Montoya-Suarez, José Luis
Zagorac, Ivana
Fernandez-Gaitero, Sara
Penning, Renske
Post, Harm
Bueno, Maria J.
Mouron, Silvana
Manso, Luis
Morente, Manuel M.
Alonso, Soledad
Serra, Violeta
Muñoz, Javier
Gómez-López, Gonzalo
Lopez-Acosta, José Francisco
Jimenez-Renard, Veronica
Gris-Oliver, Albert
Al-Shahrour, Fatima
Piñeiro-Yañez, Elena
Apala, Juan V.
author_role author
author2 Zagorac, Ivana
Fernandez-Gaitero, Sara
Penning, Renske
Post, Harm
Bueno, Maria J.
Mouron, Silvana
Manso, Luis
Morente, Manuel M.
Alonso, Soledad
Serra, Violeta
Muñoz, Javier
Gómez-López, Gonzalo
Lopez-Acosta, José Francisco
Jimenez-Renard, Veronica
Gris-Oliver, Albert
Al-Shahrour, Fatima
Piñeiro-Yañez, Elena
Apala, Juan V.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Montoya-Suarez, José Luis
Zagorac, Ivana
Fernandez-Gaitero, Sara
Penning, Renske
Post, Harm
Bueno, Maria J.
Mouron, Silvana
Manso, Luis
Morente, Manuel M.
Alonso, Soledad
Serra, Violeta
Serra, Violeta
Muñoz, Javier
Gómez-López, Gonzalo
Lopez-Acosta, José Francisco
Jimenez-Renard, Veronica
Gris-Oliver, Albert
Al-Shahrour, Fatima
Piñeiro-Yañez, Elena
Apala, Juan V.
dc.subject.es_PE.fl_str_mv Oncología
Neoplasias de la mama triple negativas
topic Oncología
Neoplasias de la mama triple negativas
https://purl.org/pe-repo/ocde/ford#3.05.00
dc.subject.ocde.es_PE.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.05.00
description El cáncer de mama triple negativo carece de marcadores pronósticos y predictivos. Se utiliza un estudio fosfoproteómico de alto rendimiento para construir una taxonomía funcional del cáncer de mama triple negativo. En resumen, el presente estudio elucida fosfocitas y quinasas implicadas en el cáncer y sugiere una clasificación clínica basada en objetivos.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2019-04-01T14:55:06Z
dc.date.available.none.fl_str_mv 2019-04-01T14:55:06Z
dc.date.issued.fl_str_mv 2018
dc.type.es_PE.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.citation.es_PE.fl_str_mv Nature Communications
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12959/114
identifier_str_mv Nature Communications
url https://hdl.handle.net/20.500.12959/114
dc.language.iso.es_PE.fl_str_mv eng
language eng
dc.rights.es_PE.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.es_PE.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.es_PE.fl_str_mv application/pdf
dc.publisher.es_PE.fl_str_mv Seguro Social de Salud (EsSalud)
dc.publisher.country.es_PE.fl_str_mv PE
dc.source.es_PE.fl_str_mv Seguro Social de Salud (EsSalud)
Repositorio Institucional EsSalud
dc.source.none.fl_str_mv reponame:ESSALUD-Institucional
instname:Seguro Social de Salud
instacron:ESSALUD
instname_str Seguro Social de Salud
instacron_str ESSALUD
institution ESSALUD
reponame_str ESSALUD-Institucional
collection ESSALUD-Institucional
bitstream.url.fl_str_mv https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/1/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/2/license.txt
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/3/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf.txt
https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/4/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf.jpg
bitstream.checksum.fl_str_mv 0f2fb920da5b3224d57c2df45e08ed53
8a4605be74aa9ea9d79846c1fba20a33
2113e06b6260bd251ac7282292c8c1e4
3f034e084cdbc9ebf061eef95554c134
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Seguro Social de Salud – ESSALUD
repository.mail.fl_str_mv bibliotecacentral@essalud.gob.pe
_version_ 1813537150276206592
spelling Montoya-Suarez, José LuisZagorac, IvanaFernandez-Gaitero, SaraPenning, RenskePost, HarmBueno, Maria J.Mouron, SilvanaManso, LuisMorente, Manuel M.Alonso, SoledadSerra, VioletaSerra, VioletaMuñoz, JavierGómez-López, GonzaloLopez-Acosta, José FranciscoJimenez-Renard, VeronicaGris-Oliver, AlbertAl-Shahrour, FatimaPiñeiro-Yañez, ElenaApala, Juan V.2019-04-01T14:55:06Z2019-04-01T14:55:06Z2018Nature Communicationshttps://hdl.handle.net/20.500.12959/114El cáncer de mama triple negativo carece de marcadores pronósticos y predictivos. Se utiliza un estudio fosfoproteómico de alto rendimiento para construir una taxonomía funcional del cáncer de mama triple negativo. En resumen, el presente estudio elucida fosfocitas y quinasas implicadas en el cáncer y sugiere una clasificación clínica basada en objetivos.application/pdfengSeguro Social de Salud (EsSalud)PEinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/Seguro Social de Salud (EsSalud)Repositorio Institucional EsSaludreponame:ESSALUD-Institucionalinstname:Seguro Social de Saludinstacron:ESSALUDOncologíaNeoplasias de la mama triple negativashttps://purl.org/pe-repo/ocde/ford#3.05.00In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.info:eu-repo/semantics/articleORIGINALIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdfIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdfapplication/pdf3291505https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/1/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf0f2fb920da5b3224d57c2df45e08ed53MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52TEXTIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdf.txtIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdf.txtExtracted texttext/plain95478https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/3/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf.txt2113e06b6260bd251ac7282292c8c1e4MD53THUMBNAILIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdf.jpgIn vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.pdf.jpgGenerated Thumbnailimage/jpeg6944https://repositorio.essalud.gob.pe/bitstream/20.500.12959/114/4/In%20vivo%20phosphoproteomics%20reveals%20kinase%20activity%20profiles%20that%20predict%20treatment%20outcome%20in%20triple-negative%20breast%20cancer.pdf.jpg3f034e084cdbc9ebf061eef95554c134MD5420.500.12959/114oai:repositorio.essalud.gob.pe:20.500.12959/1142022-09-09 03:00:17.129Repositorio Seguro Social de Salud – ESSALUDbibliotecacentral@essalud.gob.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
score 13.788314
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares